JCI - Citations to Conditionally replicating herpes vectors for cancer therapy

Citations to this article

Conditionally replicating herpes vectors for cancer therapy

Robert L. Martuza

Robert L. Martuza

Published April 1, 2000
Citation Information: J Clin Invest. 2000;105(7):841-846. https://doi.org/10.1172/JCI9744.

View: Text | PDF

Total citations by year

Year:	2024	2019	2017	2016	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	Total
Citations:	1	1	3	1	2	2	2	4	4	2	3	2	1	5	6	10	23	11	3	86

Citation information

Citations to this article (86)

Title and authors	Publication	Year
Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer Nia GE, Nikpayam E, Farrokhi M, Bolhassani A, Meuwissen R		2024
Current Applications for Overcoming Resistance to Targeted Therapies MR Szewczuk, B Qorri, M Sambi		2019
Designing and building oncolytic viruses J Maroun, M Muñoz-Alía, A Ammayappan, A Schulze, KW Peng, S Russell	Future Virology	2017
The Molecular Basis of Human Cancer WA Ricke, K Williams, J Wynder, G Palapattu, Y Wang, GR Cunha	The Molecular Basis of Human Cancer	2017
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer O Hamid, B Hoffner, E Gasal, J Hong, RD Carvajal	Cancer Immunology, Immunotherapy	2017
Neurotropic Viral Infections CJ Welsh, AJ Steelman, CR Young, HR Linsenbardt, MW Meagher	Neurotropic Viral Infections	2016
Cancer-Causing Viruses and Their Inhibitors J Yasunaga	Cancer-Causing Viruses and Their Inhibitors	2014
Molecular Imaging with Bioluminescence and PET Reveals Viral Oncolysis Kinetics and Tumor Viability D Kuruppu, AL Brownell, K Shah, U Mahmood, KK Tanabe	Cancer research	2014
A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity M Nygårdas, H Paavilainen, N Müther, CH Nagel, M Röyttä, B Sodeik, V Hukkanen	PloS one	2013
A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity M Nygårdas, H Paavilainen, N Müther, CH Nagel, M Röyttä, B Sodeik, V Hukkanen, R Klein	PloS one	2013
Oncolytic Viruses in the Treatment of Bladder Cancer KG Potts, MM Hitt, RB Moore	Advances in Urology	2012
Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV PY Wang, MA Currier, L Hansford, D Kaplan, EA Chiocca, H Uchida, WF Goins, JB Cohen, JC Glorioso, TH van Kuppevelt, X Mo, TP Cripe	Gene Therapy	2012
Cancer Screening by Systemic Administration of a Gene Delivery Vector Encoding Tumor-Selective Secretable Biomarker Expression AW Browne, JL Leddon, MA Currier, JP Williams, JS Frischer, MH Collins, CH Ahn, TP Cripe, SA Aziz	PloS one	2011
Clinical development directions in oncolytic viral therapy RM Eager, J Nemunaitis	Cancer Gene Therapy	2011
Advances in Cancer Research M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken	Advances in Cancer Research Volume 110	2011
Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems C Fillat, A Jose, X Bofill-DeRos, A Mato-Berciano, MV Maliandi, L Sobrevals	Cancers	2011
Oncolytic virotherapy reaches adolescence AM Hammill, J Conner, TP Cripe	Pediatric Blood & Cancer	2010
Host responses to herpes simplex virus and herpes simplex virus vectors V Hukkanen, H Paavilainen, RK Mattila	Future Virology	2010
Leibel and Phillips Textbook of Radiation Oncology CA Barker, TJ LoSasso, SL Wolden	Leibel and Phillips Textbook of Radiation Oncology	2010
Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures BR Minev		2010
Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses K Saito, H Shirasawa, N Isegawa, M Shiiba, K Uzawa, H Tanzawa	Oral Oncology	2009
CNS Cancer EG Meir		2009
Efficacy and safety of the oncolytic herpes simplex virus rRp450 alone and combined with cyclophosphamide MA Currier, RA Gillespie, NM Sawtell, YY Mahller, G Stroup, MH Collins, H Kambara, EA Chiocca, TP Cripe	Molecular Therapy	2008
Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus J Foloppe, J Kintz, N Futin, A Findeli, P Cordier, Y Schlesinger, C Hoffmann, C Tosch, JM Balloul, P Erbs	Gene Therapy	2008
Principles of Molecular Oncology MH Bronchud, MA Foote, G Giaccone, O Olopade, P Workman		2008
Herpes Viral Oncolysis: A Novel Cancer Therapy M Reinblatt, RH Pin, Y Fong	Journal of the American College of Surgeons	2007
Gene Therapy for Cancer KK Hunt, SA Vorburger, SG Swisher		2007
Brain Tumor Therapy using Oncolytic Herpes Simplex Virus Vectors S Miyamoto, T Todo	Japanese Journal of Neurosurgery	2006
Employing Tumor Hypoxia for Oncolytic Therapy in Breast Cancer YS Chun, PS Adusumilli, Y Fong	Journal of Mammary Gland Biology and Neoplasia	2005
Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer M Shmulevitz, P Marcato, PW Lee	Oncogene	2005
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers S Varghese, SD Rabkin, R Liu, PG Nielsen, T Ipe, RL Martuza	Cancer Gene Therapy	2005
Cancer Gene Therapy M Yamamoto, DT Curiel	Technology in cancer research & treatment	2005
Herpes simplex virus‐induced, death receptor‐dependent apoptosis and regression of transplanted human cancers Kamiyama H, Kurosaki K, Kurimoto M, Katagiri T, Nakamura Y, Kurokawa M, Sato H, Endo S, Shiraki K	Cancer Science	2005
Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen H Kasuya, TM Pawlik, JT Mullen, JM Donahue, H Nakamura, S Chandrasekhar, H Kawasaki, E Choi, KK Tanabe	Cancer research	2004
Gene Therapy and Virotherapy of Gastric Cancer: Preclinical Results and Clinical Developments DA Heideman	Digestive Diseases	2004
Herpes simplex virus-induced, death receptor-dependent apoptosis and regression of transplanted human cancers H Kamiyama, K Kurosaki, M Kurimoto, T Katagiri, Y Nakamura, M Kurokawa, H Sato, S Endo, K Shiraki	Cancer Science	2004
Diagnosis and Management of Ovarian Disorders AB Copperman, T Mukherjee, NG Kase	Diagnosis and Management of Ovarian Disorders	2004
Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin JT Mullen, JM Donahue, S Chandrasekhar, SS Yoon, W Liu, LM Ellis, H Nakamura, H Kasuya, TM Pawlik, KK Tanabe	Cancer	2004
An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency TC Liu, G Hallden, Y Wang, G Brooks, J Francis, N Lemoine, D Kirn	Molecular Therapy	2004
Herpes Simplex Virus Type-1 infection causes upregulation of telomerase activity and loss of specificity of cellular promoters Cheng-Ta Yang, Jianming Song, Xuexian Bu, Jun-Yi Chen, Yu-Sheng Cong, Silvia Bacchetti, Paul Rennie, William W.-G Jia	Gene Therapy	2003
Gene Therapy Applications to Cancer Treatment SM Scholl, S Michaelis, R McDermott	Journal of Biomedicine and Biotechnology	2003
Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10 O Teshigahara, F Goshima, K Takao, S Kohno, H Kimata, A Nakao, Y Nishiyama	Journal of Surgical Oncology	2003
Viral Oncolysis for Malignant Liver Tumors JT Mullen, KK Tanabe	Annals of Surgical Oncology	2003
Oncolytic viral therapy for human ovarian cancer using a novel replication-competent herpes simplex virus type I mutant in a mouse model A Nawa, N Nozawa, F Goshima, T Nagasaka, F Kikkawa, Y Niwa, T Nakanishi, K Kuzuya, Y Nishiyama	Gynecologic Oncology	2003
Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy G Halldén, R Hill, Y Wang, A Anand, TC Liu, NR Lemoine, J Francis, L Hawkins, D Kirn	Molecular Therapy	2003
Update on the Prevention and Treatment of Ovarian Cancer M Navo, JA Smith	Journal of Pharmacy Practice	2003
HSV-1 therapy of primary tumors reduces the number of metastases in an immune-competent model of metastatic breast cancer DL Thomas, NW Fraser	Molecular Therapy	2003
Developing Novel Oncolytic Adenoviruses through Bioselection W Yan, G Kitzes, F Dormishian, L Hawkins, A Sampson-Johannes, J Watanabe, J Holt, V Lee, T Dubensky, A Fattaey, T Hermiston, A Balmain, Y Shen	Journal of virology	2003
Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic Adenoviruses GG Vecil, FF Lang	Journal of Neuro-Oncology	2003
Regulation of herpes simplex virus 1 replication using tumor-associated promoters JT Mullen, H Kasuya, SS Yoon, NM Carroll, TM Pawlik, S Chandrasekhar, H Nakamura, JM Donahue, KK Tanabe	Annals of Surgery	2002
Encyclopedia of Cancer G Sgouros	Encyclopedia of Cancer	2002
Oncolytic Virus Therapy Using Genetically Engineered Herpes Simplex Viruses T Todo	Human Cell	2002
Regulation of Herpes Simplex Virus 1 Replication Using Tumor-Associated Promoters JT Mullen, H Kasuya, SS Yoon, NM Carroll, TM Pawlik, S Chandrasekhar, H Nakamura, JM Donahue, KK Tanabe	Annals of Surgery	2002
Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides KW Peng, S Facteau, T Wegman, D O'Kane, SJ Russell	Nature Medicine	2002
Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer A Hasenburg, DC Fischer, XW Tong, A Rojas-Martinez, C Nyberg-Hoffman, M Orlowska-Volk, P Kohlberger, RH Kaufman, I Ramzy, E Aguilar-Cordova, DG Kieback	International Journal of Gynecological Cancer	2002
Differential Susceptibility of Pediatric Sarcoma Cells to Oncolysis by Conditionally Replication-Competent Herpes Simplex Viruses NS Bharatan, MA Currier, TP Cripe	Journal of Pediatric Hematology/Oncology	2002
Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications SJ Advani, RR Weichselbaum, RJ Whitley, B Roizman	Clinical Microbiology and Infection	2002
Oncolytic Herpes Simplex Virus (G207) Therapy T Todo, MI Ebright, Y Fong, SD Rabkin		2002
Oncolytic Viruses LK Hawkins, D Kirn		2002
Reovirus Therapy of Ras-Associated Cancers PW Lee		2002
Adenoviral Vectors for Gene Therapy D Kirn	Adenoviral Vectors for Gene Therapy	2002
Gene Therapy of Cancer IV Lebedeva, CA Stein	Gene Therapy of Cancer	2002
Gene Therapy in Lung Disease K Amin	Gene Therapy in Lung Disease	2002
Gene therapy for pancreatic cancer JF Tseng, RC Mulligan	Surgical oncology clinics of North America	2002
Advances in the treatment of liver tumors SA Curley, JC Cusack, KK Tanabe, LM Ellis	Current Problems in Surgery	2002
Pediatric oncology: current views and outcomes GH Reaman	Pediatric Clinics of North America	2002
Emerging cancer-targeted therapies RJ Arceci, TP Cripe	Pediatric Clinics of North America	2002
Cytolytic viruses as potential anti-cancer agents CJ Ring	Journal of General Virology	2002
Oncolytic biotherapy: a novel therapeutic plafform Lynda K Hawkins, Nick R Lemoine, David Kirn	The Lancet Oncology	2002
Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV M Toda, Y Iizuka, T Kawase, K Uyemura, Y Kawakami	Cancer Gene Therapy	2002
Tissue-Specific Transcriptional Targeting of a Replication-Competent Retroviral Vector CR Logg, A Logg, RJ Matusik, BH Bochner, N Kasahara	Journal of virology	2002
Viral Oncolysis JT Mullen, KK Tanabe	The oncologist	2002
Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cells S Taneja, J MacGregor, S Markus, S Ha, I Mohr	Proceedings of the National Academy of Sciences	2001
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing T Todo, RL Martuza, SD Rabkin, PA Johnson	Proceedings of the National Academy of Sciences	2001
Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer TJ Jorgensen, S Katz, EK Wittmack, S Varghese, T Todo, SD Rabkin, RL Martuza	Neoplasia (New York, N.Y.)	2001
Importance of dose intensity in neurooncology clinical trials: SummaryReport of the Sixth Annual Meeting of the Blood-Brain Barrier DisruptionConsortium ND Doolittle, CP Anderson, WA Bleyer, JG Cairncross, T Cloughesy, SL Eck, P Guastadisegni, WA Hall, LL Muldoon, SJ Patel, D Peereboom, T Siegal, EA Neuwelt	Neuro-Oncology	2001
EXLOITING GENETIC ALTERATIONS TO DESIGN NOVEL THERAPIES FOR CANCER TP Cripe, CL Mackall	Hematology/Oncology Clinics of North America	2001
Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine M Toda, RL Martuza, SD Rabkin	Gene Therapy	2001
Oncolytic viruses and cancer therapy K L Norman, F Farassati, P W Lee	Cytokine & Growth Factor Reviews	2001
Importance of dose intensity in neurooncology clinical trials: Summary Report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium ND Doolittle	Neuro-Oncology	2001
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice D Grote, SJ Russell, TI Cornu, R Cattaneo, R Vile, GA Poland, AK Fielding	Blood	2001
Intravesical oncolytic viral therapy using attenuated, replication‐competent, herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model PJ Cozzi, S Malhotra, P McAuliffe, DA Kooby, HJ Federoff, B Huryk, P Johnson, PT Scardino, WD Heston, Y Fong	The FASEB Journal	2001
A Herpes Simplex Virus Type 1 γ34.5 Second-Site Suppressor Mutant That Exhibits Enhanced Growth in Cultured Glioblastoma Cells Is Severely Attenuated in Animals I Mohr, D Sternberg, S Ward, D Leib, M Mulvey, Y Gluzman	Journal of virology	2001
Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer T Hermiston	Journal of Clinical Investigation	2000
Cancer gene therapy: developments to 2000 AR Bateman, KJ Harrington, AA Melcher, RG Vile	Expert Opinion on Investigational Drugs	2000
Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer D Kirn	Oncogene	2000

Advertisement